ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: We next investigated the sensitivity of PLA-flow by spiking blood from a newly diagnosed CML patient with 19.3% BCR-ABL1-positive cells in blood samples from healthy donors in a dilution series.